Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

VDF seeks nominations for PAD and venous disease research awards

The Vascular Disease Foundation is seeking nominations for research awards through its Peripheral Arterial Disease and Venous Disease Coalitions. Research awards recognize the important research relevant to the understanding and/or treatment of arterial and venous diseases.

25 Apr 2011

Noninvasive Masimo carboxyhemoglobin can effectively screen ED patients for CO poisoning

Masimo announced today that a new study published in this month's issue of the peer-reviewed journal, Annals of Emergency Medicine, demonstrates that noninvasive Masimo carboxyhemoglobin measurements provide an "effective means for screening at-risk populations for CO poisoning" with "acceptable bias and precision" compared to invasive blood gas analysis.

25 Apr 2011

Daiichi Sankyo's LIXIANA receives Japanese marketing approval

Daiichi Sankyo Company, Limited, announced today that the company has received its first marketing approval for LIXIANA 15 mg and 30 mg tablets, by the Ministry of Health, Labor and Welfare in Japan.

22 Apr 2011

Canada Prime Minister announces $10 million fund for defibrillators and related training

Today Prime Minister Stephen Harper announced a $10 million plan to fund life-saving automated external defibrillators and related training in hockey arenas and community recreation centres across Canada.

22 Apr 2011

Employers looking for ways to reduce high blood pressure in the workplace

A group of nine Kansas City employers, their broker consultant Lockton Companies, the Kansas Department of Health and Environment, Centers for Disease and Prevention Control, and Thomson Reuters are looking for ways to reduce high blood pressure or hypertension in the workplace.

22 Apr 2011

Elderly individuals with CKD more likely to suffer from heart disease

Chronic kidney disease is common and linked with heart disease in the very elderly, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

22 Apr 2011

WSU researcher develops potential vaccine for Chlamydia

A Wayne State University School of Medicine researcher has developed a potential first ever vaccine for Chlamydia, the world's most prevalent sexually transmitted disease and the leading cause of new cases of blindness.

21 Apr 2011

Stanford and SanBio initiate SB623 Phase 1/2a clinical trial for stroke disability

The Stanford University School of Medicine and SanBio Inc. today announced the initiation of a Phase 1/2a clinical trial testing the safety and efficacy of a novel allogeneic cell therapy product, SB623, on patients suffering from stable deficits resulting from previous stroke injuries.

21 Apr 2011

Neuralstem signs MoU with BaYi Brain Hospital for ischemic stroke program in China

Neuralstem, Inc. (NYSE Amex: CUR) announced it has signed a Memorandum of Understanding with BaYi Brain Hospital in Beijing, China.

21 Apr 2011

America’s best loved drugs: Report

According to the latest report from consulting firm IMS Health, Americans are consuming a lot of prescription drugs. And they seem especially fond of those to lower their cholesterol, relieve heartburn, aid in depressive disorders and lessen pain. Overall, however, their spending on such drugs is slowing.

20 Apr 2011

Stealth Peptides launches mitochondrion targeting compound Bendavia at Experimental Biology 2011

Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative mitochondrial therapies, introduced its lead clinical candidate, Bendavia™, a novel compound that targets the mitochondrion, during multiple scientific sessions of the Experimental Biology 2011 meeting.

20 Apr 2011

Swinburne University of Technology acquires Elekta's Neuromag TRIUX MEG system

Certain brain processes happen in the blink of an eye – and even faster – which has made pinpointing these events virtually impossible. The advent of magnetoencephalography (MEG) changed all that, enabling researchers to capture brain electrical activity measured in milliseconds, and offering the potential to reveal the nature of innumerable brain disorders and diseases.

From Elekta 20 Apr 2011

Combination therapy restores skilled use of limb in rodent model

After the acute treatment window closes, the only effective treatment for stroke is physical/occupational therapy. Now scientists from Children's Hospital Boston report a two-pronged molecular therapy that leads to significant recovery of skilled motor function in a rat model of stroke.

20 Apr 2011

AADSM event to discuss latest advances in sleep-disordered breathing research

Nearly 800 dental sleep medicine professionals from around the world will gather at the 20th Anniversary Meeting of the American Academy of Dental Sleep Medicine, which will take place Saturday, June 11, 2011, at the Hilton Minneapolis in Minneapolis, Minn.

19 Apr 2011

New research: 56% of Canadians with AF do not fear having fatal stroke

New research reveals more than half of Canadians living with atrial fibrillation do not fear having a stroke, despite AF-related strokes being more severe, debilitating and twice as likely to be fatal.

19 Apr 2011

FDA approval of Pipeline Embolization Device offers better options for treatment of large/giant aneurysms

The recent U.S. Food and Drug Administration (FDA) approval of a brain aneurysm device has opened the door for neurosurgeons at Jefferson Hospital for Neuroscience (JHN) to offer advanced treatment to patients suffering from large or giant aneurysms who otherwise have limited, effective options.

19 Apr 2011

People with infectious mononucleosis, low UVB exposure may face high risk of MS

New research suggests that people who are exposed to low levels of sunlight coupled with a history of having a common virus known as mononucleosis may be at greater odds of developing multiple sclerosis than those without the virus.

19 Apr 2011

Anti-depressants spur creation and survival of new brain cells after brain injury

Anti-depressants may help spur the creation and survival of new brain cells after brain injury, according to a study by neurosurgeons at the University of Rochester Medical Center.

19 Apr 2011

First bypass surgery to restore lost brain tissue performed at Krembil Neuroscience Centre

Neurosurgeons at the Krembil Neuroscience Centre, Toronto Western Hospital, have for the first time, initiated the restoration of lost brain tissue through brain bypass surgery in patients where blood flow to the brain is impaired by cerebrovascular disease. The study, which involved 29 patients, was published online in the journal Stroke.

19 Apr 2011

Nerve disorder expert Jack Griffin passes away

Jack Griffin, an internationally acclaimed and admired expert on diseases of the peripheral nervous system, founding director of the Johns Hopkins Brain Science Institute, and former director of Hopkins School of Medicine's Department of Neurology, died Saturday, April 16, after a long battle with bladder cancer. He was 69.

18 Apr 2011

Stroke News and Research

Further Reading

VDF seeks nominations for PAD and venous disease research awards

Noninvasive Masimo carboxyhemoglobin can effectively screen ED patients for CO poisoning

Daiichi Sankyo's LIXIANA receives Japanese marketing approval

Canada Prime Minister announces $10 million fund for defibrillators and related training

Employers looking for ways to reduce high blood pressure in the workplace

Elderly individuals with CKD more likely to suffer from heart disease

WSU researcher develops potential vaccine for Chlamydia

Stanford and SanBio initiate SB623 Phase 1/2a clinical trial for stroke disability

Neuralstem signs MoU with BaYi Brain Hospital for ischemic stroke program in China

America’s best loved drugs: Report

Stealth Peptides launches mitochondrion targeting compound Bendavia at Experimental Biology 2011

Swinburne University of Technology acquires Elekta's Neuromag TRIUX MEG system

Combination therapy restores skilled use of limb in rodent model

AADSM event to discuss latest advances in sleep-disordered breathing research

New research: 56% of Canadians with AF do not fear having fatal stroke

FDA approval of Pipeline Embolization Device offers better options for treatment of large/giant aneurysms

People with infectious mononucleosis, low UVB exposure may face high risk of MS

Anti-depressants spur creation and survival of new brain cells after brain injury

First bypass surgery to restore lost brain tissue performed at Krembil Neuroscience Centre

Nerve disorder expert Jack Griffin passes away

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News